Country for PR: China
Contributor: PR Newswire Asia (China)
Monday, January 17 2022 - 16:09
MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker
CLAMART, France, Jan. 17, 2022 /PRNewswire-Asianet/ --

MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, 
headquartered in France, recently received PMDA Japanese regulation agency 
approval for its latest range of implantable pacemakers, Alizea. The devices 
are equipped with Bluetooth technology for streamlined remote monitoring when 
paired with MicroPort CRM's SmartView Connect home monitor, already approved in 

Alizea pacemakers allow cardiologists to monitor devices remotely. The 
SmartView Connect home monitor is designed to be placed at the patient's 
bedside to allow for the regular transmission of detailed reports to the 
cardiologist on the functioning of the pacing system, removing the need for 
patients to visit the hospital for simple routine examinations, and thus 
reducing the burden on the healthcare system. Alizea pacemakers and the 
SmartView Connect home monitor work together to provide the cardiologist with 
timely alerts and transmissions triggered by patients when they present 
symptoms, leading to faster and more efficient patient care.

Noboru Shimizu, VP of MicroPort CRM Sales Japan, commented, "Around 64,000 
patients are implanted with a pacemaker each year in Japan, and coupled with 
the difficulties that have arisen from the current health crisis, there is a 
growing need to monitor patients remotely, without them having to travel. 
Thanks to Alizea pacemakers and its SmartView Connect monitor, we are 
positioning ourselves in the Japanese market with the very best in cardiac 
pacing. I am convinced that this will allow us to strengthen our presence in 

Benoît Clinchamps, President of MicroPort CRM, noted, "We successfully launched 
Alizea in Europe in June 2021, and Japan is the second region to benefit from 
its advanced technological functions. As part of our commitment to improve the 
lives of as many patients as possible, and to support healthcare professionals 
in their mission, we will continue to deploy Alizea and Smartview Connect 
around the world."

About MicroPort CRM

MicroPort CRM is a pioneering company in the field of Cardiac Rhythm Management 
(CRM), and a subsidiary of MicroPort Scientific Corporation (stock code: 
00853.HK), with world headquarters in Clamart, near Paris, France. Through its 
long-standing expertise in CRM, MicroPor CRM develops, manufactures and markets 
cardiac pacemakers, implantable cardiac defibrillators, cardiac 
resynchronization systems and ECG diagnostic solutions for the management of 
cardiac rhythm disorders and heart failure, globally. 

For more information, please refer to

SOURCE:  MicroPort

Image Attachments Links:


   Caption: Alizea Bluetooth Pacemaker


image-1.jpg image-2.jpg